022 24172311
Sections
Search
DealCurry
Equity
Venture Capital
Private Equity
M&A

Banner
DataBoard Demo
Mergers & Acquisitions | 28 April 2011

Biocon To Sell Its 78% Stake In AxiCorp For $58 Mn

by Deeshesh Chheda
Biocon To Sell Its 78% Stake In AxiCorp For $58 Mn
Share on Social Media Email Facebook Twitter Linkedin
 
@deeshesh

Biocon Ltd will be selling its entire 78% stake in it's German unit, AxiCorp GmbH, to minority shareholders, for 40 million euros ($58.2 Mn).

AxiCorp was the licensee for Biocon's insulin and Glargine products in Germany and had the sole responsibility for commercialising these products.

Transactio Reference: Business Standard


{TAG_10522_1303984599}

Religare To Raise Rs 800 Cr Via Rights Issue

Religare To Raise Rs 800 Cr Via Rights Issue

Religare Enterprises Limited will raise Rs.800 Cr through rights issue, with an option to increase the issue size by additional 10%.

Read More...

World Bankā€™s Investment Arm IFC to Invest $20 Million in Future Consumer Enterprise

World Bankā€™s Investment Arm IFC to Invest $20 Million in Future Consumer Enterprise

International Financial Corp (IFC), the private lending arm of the World Bank, has revealed that it intends to invest in two leading Bangladeshi companies. The aim is to give impetus to the government’s efforts to upgrade Bangladesh’s infrastructure and expand its exports.

Read More...
Subscribe
Enter your Email address
to receive all the news